..
2. No serious reaction has been observed, the vaccine’s developer, CanSino Biologics said.
— BFM News (@NewsBFM) October 27, 2022
Last month, it was reported that Malaysia had approved for the vaccine to undergo clinical trials.
..
..
..
2. No serious reaction has been observed, the vaccine’s developer, CanSino Biologics said.
— BFM News (@NewsBFM) October 27, 2022
Last month, it was reported that Malaysia had approved for the vaccine to undergo clinical trials.
..
..